HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$3.31
Day range
$3.30 - $3.55
Year range
$3.00 - $5.48
Market cap
108.73M CAD
Avg Volume
43.30K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 14.08M | -12.17% |
Operating expense | 12.30M | -20.88% |
Net income | -4.84M | 29.81% |
Net profit margin | -34.39 | 20.08% |
Earnings per share | — | — |
EBITDA | 3.62M | -29.76% |
Effective tax rate | 1.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.54M | -19.57% |
Total assets | 171.74M | -20.21% |
Total liabilities | 92.41M | -18.53% |
Total equity | 79.33M | — |
Shares outstanding | 31.79M | — |
Price to book | 1.32 | — |
Return on assets | -2.61% | — |
Return on capital | -3.02% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -4.84M | 29.81% |
Cash from operations | 1.50M | -72.03% |
Cash from investing | -1.50M | -3,650.00% |
Cash from financing | -15.10M | -251.81% |
Net change in cash | -14.98M | -1,809.47% |
Free cash flow | 15.13M | 69.61% |
About
Founded
2014
Website
Employees
91
